What's breaking now, across thousands of outlets.
(RTTNews) - AbbVie (ABBV) reported positive results from the Phase 2 APEX Part B study of zumilokibart, in adults with moderate to severe atopic dermatitis.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The Central Bank of Nigeria (CBN) sold approximately N4.686 trillion in Open Market Operations (OMO) bills at its September 29, 2026 auction, nearly double the N2.5 trillion originally offered and…
Treasury yields retreated from multiyear highs in Asian trade on Wednesday after Federal Reserve speeches lowered market expectations of interest-rate hikes.
Headline earnings climb 19% to R9.5bn.
Bashir Ojulari, the group chief executive officer, Nigerian National Petroleum Company (NNPC) Limited has announced that no date has been read more We dont have a date for IPO yet – Ojulari
Pessimism around real estate stocks is so severe as interest rates climb that conditions exist for a dramatic reversal to the benefit of investors with good timing.
